Literature DB >> 12755662

Metabolic syndrome in patients with schizophrenia.

Tuula Heiskanen1, Leo Niskanen, Riitta Lyytikäinen, Pirjo I Saarinen, Jukka Hintikka.   

Abstract

BACKGROUND: Our aim was to study the frequency of metabolic syndrome and associated factors in patients with schizophrenia.
METHOD: The study group consisted of 35 outpatients with long-term schizophrenia defined by DSM-IV criteria. Patients were assessed for the presence of metabolic syndrome, which was defined by the criteria of the National Cholesterol Education Program. All patients were on antipsychotic medication. Data were collected from Jan. 1, 2001, to Aug. 30, 2001.
RESULTS: Metabolic syndrome was found in 37% (N = 13) of the patients, and it was associated inversely with the total daily dose of, but not with any specific type of, antipsychotic drug.
CONCLUSION: The results suggest that metabolic syndrome is common among patients with schizophrenia, and it may be far more common than in general populations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12755662     DOI: 10.4088/jcp.v64n0513

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  42 in total

1.  A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychotics.

Authors:  Benjamin U Nwosu; Bruce Meltzer; Louise Maranda; Carol Ciccarelli; Daniel Reynolds; Laura Curtis; Jean King; Jean A Frazier; Mary M Lee
Journal:  J Pediatr Endocrinol Metab       Date:  2011       Impact factor: 1.634

2.  Prevalence of metabolic syndrome in a predominantly cuban, psychiatrically ill, and homeless population.

Authors:  Rafael A Rivas-Vazquez; Iruma Bello; Manual Sarria; Noel D Fernandez; Gustavo J Rey
Journal:  Prim Care Companion CNS Disord       Date:  2011

3.  Early intervention in psychosis: keeping the body in mind.

Authors:  David Shiers; Peter B Jones; Steve Field
Journal:  Br J Gen Pract       Date:  2009-06       Impact factor: 5.386

4.  Relationship Between Metabolic Syndrome and Clinical Features, and Its Personal-Social Performance in Patients with Schizophrenia.

Authors:  Omer Saatcioglu; Murat Kalkan; Nurhan Fistikci; Sakire Erek; Kasim Candas Kilic
Journal:  Psychiatr Q       Date:  2016-06

5.  Metabolic issues in schizophrenic patients receiving antipsychotic treatment.

Authors:  Aditi Gupta; Gora Dadheech; Dharamveer Yadav; Praveen Sharma; Shiv Gautam
Journal:  Indian J Clin Biochem       Date:  2014-01-23

6.  A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls.

Authors:  Davy Vancampfort; Martien Wampers; Alex J Mitchell; Christoph U Correll; Amber De Herdt; Michel Probst; Marc De Hert
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

7.  Metabolic syndrome in people with schizophrenia: a review.

Authors:  Marc DE Hert; Vincent Schreurs; Davy Vancampfort; Ruud VAN Winkel
Journal:  World Psychiatry       Date:  2009-02       Impact factor: 49.548

8.  Prevalence of Metabolic Syndrome in Hispanic and Non-Hispanic Patients With Schizophrenia.

Authors:  Martha M. Kato; M Beatriz Currier; Christina M. Gomez; Lacresha Hall; Mercedes Gonzalez-Blanco
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

9.  The contribution of abdominal obesity and dyslipidemia to metabolic syndrome in psychiatric patients.

Authors:  Sung-Hwan Kim; Kiwon Kim; Mi Hyang Kwak; Hak Jin Kim; Hong-Sup Kim; Ki Hoon Han
Journal:  Korean J Intern Med       Date:  2010-06-01       Impact factor: 3.165

10.  European network for promoting the physical health of residents in psychiatric and social care facilities (HELPS): background, aims and methods.

Authors:  Prisca Weiser; Thomas Becker; Carolin Losert; Köksal Alptekin; Loretta Berti; Lorenzo Burti; Alexandra Burton; Mojca Dernovsek; Eva Dragomirecka; Marion Freidl; Fabian Friedrich; Aneta Genova; Arunas Germanavicius; Ulaş Halis; John Henderson; Peter Hjorth; Taavi Lai; Jens Ivar Larsen; Katarzyna Lech; Ramona Lucas; Roxana Marginean; David McDaid; Maya Mladenova; Povl Munk-Jørgensen; Alexandru Paziuc; Petronela Paziuc; Stefan Priebe; Katarzyna Prot-Klinger; Johannes Wancata; Reinhold Kilian
Journal:  BMC Public Health       Date:  2009-08-28       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.